377 related articles for article (PubMed ID: 22972508)
1. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.
Zhao Q; Ming J; Liu C; Shi L; Xu X; Nie X; Huang T
Ann Surg Oncol; 2013 Mar; 20(3):746-52. PubMed ID: 22972508
[TBL] [Abstract][Full Text] [Related]
2. Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis.
Liu C; Wang S; Zeng W; Guo Y; Liu Z; Huang T
Sci Rep; 2017 May; 7(1):1846. PubMed ID: 28500312
[TBL] [Abstract][Full Text] [Related]
3. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection.
Wada N; Duh QY; Sugino K; Iwasaki H; Kameyama K; Mimura T; Ito K; Takami H; Takanashi Y
Ann Surg; 2003 Mar; 237(3):399-407. PubMed ID: 12616125
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma.
Park JP; Roh JL; Lee JH; Baek JH; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Am J Surg; 2014 Sep; 208(3):412-8. PubMed ID: 24602323
[TBL] [Abstract][Full Text] [Related]
5. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
[TBL] [Abstract][Full Text] [Related]
6. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
[TBL] [Abstract][Full Text] [Related]
7. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
8. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
9. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma.
Vergez S; Sarini J; Percodani J; Serrano E; Caron P
Eur J Surg Oncol; 2010 Aug; 36(8):777-82. PubMed ID: 20584589
[TBL] [Abstract][Full Text] [Related]
10. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
[TBL] [Abstract][Full Text] [Related]
11. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
12. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
[TBL] [Abstract][Full Text] [Related]
13. The influence of papillary thyroid microcarcinomas size on the occurrence of lymph node metastases.
Goran M; Markovic I; Buta M; Gavrilovic D; Cvetkovic A; Santrac N; Rakovic M; Milijic NM; Dzodic R
J BUON; 2019; 24(5):2120-2126. PubMed ID: 31786884
[TBL] [Abstract][Full Text] [Related]
14. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
Gui CY; Qiu SL; Peng ZH; Wang M
J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
[TBL] [Abstract][Full Text] [Related]
16. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
Elbasan O; Ilgın C; Gogas Yavuz D
Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
[TBL] [Abstract][Full Text] [Related]
17. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2008 Sep; 15(9):2482-6. PubMed ID: 18612697
[TBL] [Abstract][Full Text] [Related]
18. Impact of tumor size on subclinical central lymph node metastasis in papillary thyroid microcarcinoma depends on age.
Kim JY; Jung EJ; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC; Choi SK; Ha WS
World J Surg Oncol; 2015 Feb; 13():88. PubMed ID: 25886181
[TBL] [Abstract][Full Text] [Related]
19. Can ratio of the biggest tumor diameter to total tumor diameter be a new parameter in the differential diagnosis of agressive and favorable multifocal papillary thyroid microcarcinoma?
Tam AA; Özdemir D; Çuhacı N; Başer H; Dirikoç A; Aydın C; Yazgan AK; Ersoy R; Çakır B
Oral Oncol; 2017 Feb; 65():1-7. PubMed ID: 28109462
[TBL] [Abstract][Full Text] [Related]
20. Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis.
Kwak JY; Kim EK; Kim MJ; Son EJ; Chung WY; Park CS; Nam KH
Ann Surg Oncol; 2009 May; 16(5):1348-55. PubMed ID: 19224278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
